Press Releases

 
Press Releases
  Date Title View
Mar 9, 2009
LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present at the Cowen and Company 29th Annual Health Care Conference on Monday, March 16, 2009 at 11:00 a.m. Eastern Time.  The conference will be held March 16-19, 2009 at The Boston Marriott C...
Jan 5, 2009
LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the 27th Annual J.P. Morgan Healthcare Conference, being held at the Westin St. Francis Hotel in San Francisco, California.  Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Monday...
Nov 24, 2008
LEXINGTON, MA -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the 20th Annual Piper Jaffray Health Care Conference, being held at The New York Palace in New York City. Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Tuesday, December 2, 2008 at...
Oct 28, 2008
LEXINGTON, MA -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the Oppenheimer 19th Annual Healthcare Conference, being held at the Waldorf-Astoria Hotel in New York City. Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Tuesday, November 4, 2008 at 8:20 a....
Oct 27, 2008
Washington, DC – Concert Pharmaceuticals, Inc. today announced findings from a preclinical study suggesting that C-20081, a novel, deuterium-containing oxazolidinone antibiotic, may be suitable for once-daily oral and intravenous dosing.  In the preclinical study, C-20081 had a 43% increase in plasma half-life co...
Oct 15, 2008
Lexington, MA – Concert Pharmaceuticals, Inc. today announced that it will be presenting at the 2008 Boston Biotech R&D Conference being held at Harvard Medical School in Cambridge, Massachusetts.  Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Wednesday, Octobe...
Oct 6, 2008
Lexington, MA – Concert Pharmaceuticals, Inc. today announced that Steven B. Bernitz has joined the company as its Senior Vice President and Chief Business Officer.  In this role, he will be a member of Concert’s executive management team, designing and implementing strategic planning initiatives and having overall responsib...
Sep 29, 2008
Lexington, MA - Concert Pharmaceuticals, Inc. announced today that it will be presenting at the Third Annual JMP Securities Healthcare Focus Conference, being held at the Le Parker Meridien in New York City. Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Monday, October 6, 200...
Sep 25, 2008
Lexington, MA – Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase I study in healthy volunteers to evaluate the safety, tolerability and pharmacokinetics of CTP-347, a novel deuterium-containing serotonin modulator created by Concert researchers.  Concert intends to evaluate CTP...
Sep 25, 2008
Results Presented at the North American Menopause Society’s 2008 Annual Meeting Orlando, FL – Concert Pharmaceuticals, Inc. announced today the presentation of data from a preclinical study demonstrating the potential of CTP-347, its novel deuterium-containing serotonin modulat...
FirstPrevious
...
17
NextLast
= add release to Briefcase